172 related articles for article (PubMed ID: 17472654)
1. Pharmacokinetics and physiological effects of two intravenous infusion rates of morphine in conscious dogs.
Guedes AG; Papich MG; Rude EP; Rider MA
J Vet Pharmacol Ther; 2007 Jun; 30(3):224-33. PubMed ID: 17472654
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
Guedes AG; Papich MG; Rude EP; Rider MA
J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
4. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
Guedes AG; Papich MG; Rude EP; Rider MA
J Vet Pharmacol Ther; 2007 Dec; 30(6):516-22. PubMed ID: 17991219
[TBL] [Abstract][Full Text] [Related]
5. Use of a von Frey device for evaluation of pharmacokinetics and pharmacodynamics of morphine after intravenous administration as an infusion or multiple doses in dogs.
KuKanich B; Lascelles BD; Papich MG
Am J Vet Res; 2005 Nov; 66(11):1968-74. PubMed ID: 16334958
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
7. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of morphine administered by constant-rate intravenous infusion or intermittent intramuscular injection in dogs.
Lucas AN; Firth AM; Anderson GA; Vine JH; Edwards GA
J Am Vet Med Assoc; 2001 Mar; 218(6):884-91. PubMed ID: 11294312
[TBL] [Abstract][Full Text] [Related]
9. Does intraosseous equal intravenous? A pharmacokinetic study.
Von Hoff DD; Kuhn JG; Burris HA; Miller LJ
Am J Emerg Med; 2008 Jan; 26(1):31-8. PubMed ID: 18082778
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs.
KuKanich B; Lascelles BD; Papich MG
J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817
[TBL] [Abstract][Full Text] [Related]
11. Effects of ketoconazole on the pharmacokinetics and pharmacodynamics of morphine in healthy Greyhounds.
Kukanich B; Borum SL
Am J Vet Res; 2008 May; 69(5):664-9. PubMed ID: 18447799
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of a new sustained-release formulation of morphine.
Araico A; Saadeddin A; Torres-Molina F; Peris JE
Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
Chism JP; Rickert DE
Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.
Lankveld DP; Driessen B; Soma LR; Moate PJ; Rudy J; Uboh CE; van Dijk P; Hellebrekers LJ
J Vet Pharmacol Ther; 2006 Dec; 29(6):477-88. PubMed ID: 17083451
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, pharmacodynamics, and analgesic effects of morphine after rectal, intramuscular, and intravenous administration in dogs.
Barnhart MD; Hubbell JA; Muir WW; Sams RA; Bednarski RM
Am J Vet Res; 2000 Jan; 61(1):24-8. PubMed ID: 10630773
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.
Lötsch J; Stockmann A; Kobal G; Brune K; Waibel R; Schmidt N; Geisslinger G
Clin Pharmacol Ther; 1996 Sep; 60(3):316-25. PubMed ID: 8841154
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of a constant rate infusion of fentanyl (5 μg/kg/h) in awake cats.
Ambros B; Alcorn J; Duke-Novakovski T; Livingston A; Dowling PM
Am J Vet Res; 2014 Aug; 75(8):716-21. PubMed ID: 25061702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
